Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WARM-HF Stage 2
NCT07687862Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Randomised, open-label trial in heart failure (HF) and Atrial fibrillation (AFib) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Composite outcome of death or HF hospitalization at 2 years. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
heart failure (HF)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07687862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07687862.